SRTD Biotech
SRTD Biotech is a German biotechnology company developing an RNA-based therapeutic platform designed to selectively activate treatments in diseased cells, targeting cancer, viral infections and autoimmune diseases.
SRTD Biotech has raised €32M across 1 funding round from 6 investors, most recently a Seed round in Nov 2026. Based in Jülich, Germany; active in Healthtech. Data as of Nov 2026.
Jülich, Germanysrtd-biotech.com ↗
Total raised
€32M
€31,500,000
Funding rounds
1
Investors
6
distinct backers
Active since
2026-11
latest 2026-11
Funding by year
EUR raised per year · 2026 YTDSRTD Biotech — funding by year — interactive chart.
Data table
| SRTD Biotech — funding by year | |
|---|---|
| 2026 | €32M |
Signals
High confidenceRaise-next likelihood14
base rate 44% for Seed
- ▼ Raised very recently
- ▼ Low backer re-investment
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-11-09 | Seed | €32M | Anobis Asset,Boehringer Ingelheim Venture Fund,High-Tech Gründerfonds (HTGF),Lilly,Mérieux Equity Partners,NRW.BANK | View deal → |
Investors
6Related news
Similar companies
same sector, similar size- Avelios Medical€32MGermany · Healthtech
- tacalyx€18MGermany · Healthtech
- HelloBetter€31MGermany · Healthtech
- one.five€25MGermany · Healthtech
- Recare Solutions€42MGermany · Healthtech
- Kupando€23MGermany · Healthtech
Global coverage: FundingData